NIH Small Business Innovation Research (SBIR) Phase IIB Strategic Breakthrough Award (Parent [R44] Clinical Trial Optional)
| Country | United States |
|---|---|
| Deadline | 2029-04-05 (865 days left) |
| Published | 2026-05-28 |
| Sectors | Health & life sciences, Research & innovation, SME & startup support |
| Source | Grants.gov (US) |
Summary
Funding opportunity PA-27-101. CFDA: 93.853, 93.838, 93.839, 93.866, 93.307, 93.847, 93.394, 93.837, 93.855, 93.313, 93.393, 93.865, 93.350, 93.242, 93.867, 93.233, 93.351, 93.840, 93.859, 93.273, 93.395
The buyer, the value, the full description and the link to the official notice are available with a free account.